Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
13
|
pubmed:dateCreated |
1987-5-26
|
pubmed:language |
dut
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0028-2162
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
28
|
pubmed:volume |
131
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
515-9
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:3574509-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:3574509-Cisplatin,
pubmed-meshheading:3574509-Combined Modality Therapy,
pubmed-meshheading:3574509-Doxorubicin,
pubmed-meshheading:3574509-Fluorouracil,
pubmed-meshheading:3574509-Humans,
pubmed-meshheading:3574509-Mitomycins,
pubmed-meshheading:3574509-Stomach Neoplasms
|
pubmed:year |
1987
|
pubmed:articleTitle |
[Cytostatic agents in the treatment of stomach carcinoma].
|
pubmed:publicationType |
Journal Article
|